# OnCo record antengene (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/antengene/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "antengene" ;
  schema:name "Antengene"@en ;
  schema:alternateName "Antengene Corporation"@en, "德琪医药"@en ;
  schema:description "Antengene is a Shanghai company that brought the XPO1 inhibitor selinexor to China and other Asia-Pacific markets and develops its own pipeline of blood cancer and solid tumour drugs."@en ;
  schema:url <https://onco.cc/companies/antengene/>, <https://www.antengene.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.antengene.com>, <https://clinicaltrials.gov/search?lead=Antengene> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/xpo1/> ;
  onco:drugs <https://onco.cc/drugs/selinexor/> .